Toyota|$17.73 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.08 (¥4,320)-0.76%▼ (in JPY terms)
SoftBank|$21.41 (¥3,416)-3.69%▼ (in JPY terms)
MUFG|$21.41 (¥3,415)-1.73%▼ (in JPY terms)
Keyence|$460.39 (¥73,450)-1.52%▼ (in JPY terms)
Nintendo|$55.75 (¥8,894)+1.38%▲ (in JPY terms)
NTT|$1.06 (¥169)+0.12%▲ (in JPY terms)
Takeda|$43.48 (¥6,937)+0.16%▲ (in JPY terms)
Tokyo Electron|$55.12 (¥8,794)-7.05%▼ (in JPY terms)
Recruit|$108.59 (¥17,325)-1.34%▼ (in JPY terms)
ITOCHU|$15.02 (¥2,396)-0.66%▼ (in JPY terms)
Honda|$11.51 (¥1,836)-0.33%▼ (in JPY terms)
Shin-Etsu|$35.24 (¥5,622)-1.44%▼ (in JPY terms)
Tokio Marine|$3.74 (¥597)+0.05%▲ (in JPY terms)
Fast Retailing|$524.89 (¥83,740)+1.97%▲ (in JPY terms)
Toyota|$17.73 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.08 (¥4,320)-0.76%▼ (in JPY terms)
SoftBank|$21.41 (¥3,416)-3.69%▼ (in JPY terms)
MUFG|$21.41 (¥3,415)-1.73%▼ (in JPY terms)
Keyence|$460.39 (¥73,450)-1.52%▼ (in JPY terms)
Nintendo|$55.75 (¥8,894)+1.38%▲ (in JPY terms)
NTT|$1.06 (¥169)+0.12%▲ (in JPY terms)
Takeda|$43.48 (¥6,937)+0.16%▲ (in JPY terms)
Tokyo Electron|$55.12 (¥8,794)-7.05%▼ (in JPY terms)
Recruit|$108.59 (¥17,325)-1.34%▼ (in JPY terms)
ITOCHU|$15.02 (¥2,396)-0.66%▼ (in JPY terms)
Honda|$11.51 (¥1,836)-0.33%▼ (in JPY terms)
Shin-Etsu|$35.24 (¥5,622)-1.44%▼ (in JPY terms)
Tokio Marine|$3.74 (¥597)+0.05%▲ (in JPY terms)
Fast Retailing|$524.89 (¥83,740)+1.97%▲ (in JPY terms)

2026-06-24 Astellas Pharma Inc. “The antibody-drug conjugate PADCEV™ (enfortumab vedotin) has received approval in Europe for combination therapy with pembrolizumab for resectable muscle-invasive bladder cancer that is unsuitable for cisplatin, providing a new treatment option as adjuvant therapy before and after surgery.”

2026-06-24 Astellas Pharma Inc. “The antibody-drug conjugate PADCEV™ (enfortumab vedotin) has received a … 続きを読む